Nanome

NANOMETM nanoparticulate delivery system and related NANOME services for delivering taxanes and other drugs to subjects suffering from cancer.

BENEFITS

  • Localized and targeted delivery of chemotherapeutics
  • Reduced adverse side effects of chemotherapeutics
  • Reduced toxicity of chemotherapeutics

DETAILED SUMMARY

Please contact us for formulations using our new  NANOMETM nanoparticulate drug delivery system for a wide variety of drugs to overcome major obstacles like poor solubility, poor bioavailability and P-gp mediated efflux.  In addition, the NANOMETM drug delivery system reduces adverse side effects and toxicity of chemotherapeutics. NANOME services, which include research and development of drug delivery systems for taxanes and other cancer treatment drugs,  are available. 

INTELLECTUAL PROPERTY STATUS

US 8,242,165 B2 issued August 14, 2012.

NANOME (Class 42) Registration No. 3,687,057 issued September 22, 2009.

Some Applications of NANOMETM